BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 31, 2007
View Archived Issues
Summit and Evolva to codevelop new drugs for infectious diseases
Read More
Update on Protalex's phase I trial of PRTX-100
Read More
Positive results for AVI-5126 cardiovascular restenosis preventer
Read More
BioLineRx begins phase II trial of BL-1020 for schizophrenia
Read More
GSK declines option to develop Exelixis compound XL-647 licensed to SEI
Read More
Osiris and Genzyme to codevelop Prochymal for ARS
Read More
Siga and USAMRIID identify small-molecule inhibitors of Filoviridae viral entry
Read More
Abbott discloses novel antiviral agents in recent patent
Read More
Pyrazoline-based SARM with strong anabolic and partial androgenic/antiandrogenic effects in rats
Read More
Intranasal immunization with VLP vaccine protects against pandemic flu virus
Read More
Trypanosoma vaccine candidates comprised of tubulin peptides and mosaic virus
Read More
Genzyme reports second quarter 2007 results
Read More
CSL Behring announces FDA approval of Privigen
Read More
Omrix submits appplication to the EMEA for marketing approval of Evicel
Read More
Lybrel, first low-dose combination oral contraceptive now available in the U.S.
Read More
Safety and tolerability of HPV16 E6E7 vaccine reported in HIV-positive, HPV-infected patients
Read More
Significant antiviral activity with etravirine in HIV-positive, NNRTI-resistant patients
Read More
Fully human MAbs effective against highly pathogenic avian influenza virus
Read More
Positive results for Intellect's single-dose phase Ia trial of Oxigon
Read More
OSI transfers all rights to E-10030 and PDGF program to Ophthotech
Read More
ImClone and Bristol-Myers expand Erbitux codevelopment agreement
Read More
Positive preclinical results for Gene Logic's GL-1001 for IBD
Read More
Abbott begins phase I study of ABT-560 for CNS disorders
Read More
Epix presents new 5-HT6 receptor antagonist with beneficial effects in animal model of schizophrenia
Read More